[go: up one dir, main page]
More Web Proxy on the site http://driver.im/
You seem to have javascript disabled. Please note that many of the page functionalities won't work as expected without javascript enabled.
 
 
Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Article Types

Countries / Regions

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Search Results (10,461)

Search Parameters:
Keywords = miRNA-7

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
16 pages, 1636 KiB  
Article
MicroRNAs miR-148a-3p, miR-425-3p, and miR-20a-5p in Patients with IgA Nephropathy
by Jarosław Przybyciński, Michał Czerewaty, Ewa Kwiatkowska, Violetta Dziedziejko, Krzysztof Safranow, Leszek Domański and Andrzej Pawlik
Genes 2025, 16(2), 125; https://doi.org/10.3390/genes16020125 (registering DOI) - 23 Jan 2025
Abstract
Background/Objectives: IgA nephropathy (IgAN) is one of the most common forms of glomerulonephritis leading to renal failure. MicroRNAs have been shown to play an important role in the pathogenesis and clinical course of IgA nephropathy; therefore, they offer the possibility of noninvasive diagnosis [...] Read more.
Background/Objectives: IgA nephropathy (IgAN) is one of the most common forms of glomerulonephritis leading to renal failure. MicroRNAs have been shown to play an important role in the pathogenesis and clinical course of IgA nephropathy; therefore, they offer the possibility of noninvasive diagnosis of this disease and have some value in predicting disease prognosis. This study aimed to evaluate the plasma levels of miR-148a-3p, miR-425-3p, and miR-20a-5p in patients with IgA nephropathy and their correlation with selected clinical parameters. Methods: This study included 44 patients with IgA nephropathy and 46 control subjects. Results: The results of our study indicated that in patients with IgA nephropathy, the increased plasma levels of miR-148a-3p and miR-425-3p correlated negatively with eGFR values. According to the Haas classification, plasma levels of miR-20a-5p were statistically significantly increased in patients with histopathological changes classified as Stages 3, 4, and 5 compared with patients with histopathological changes classified as Stages 1 and 2. Conclusions: The results of our study suggest the possible involvement of miR-148a-3p, miR-425-3p, and miR-20a-5p in the pathogenesis of IgA nephropathy. Full article
(This article belongs to the Special Issue Epigenetics in Human Development and Diseases)
Show Figures

Figure 1

Figure 1
<p>Plasma levels of miR-20a-5p in patients with IgA nephropathy and control subjects.</p>
Full article ">Figure 2
<p>Plasma levels of miR-148a-3p in patients with IgA nephropathy and control subjects. * <span class="html-italic">p</span> = 0.0002, Mann–Whitney U test.</p>
Full article ">Figure 3
<p>Plasma levels of miR-425-3p in patients with IgA nephropathy and control subjects. * <span class="html-italic">p</span> = 0.01, Mann–Whitney U test.</p>
Full article ">Figure 4
<p>Plasma levels of miR-20a-5p in patients with and without diagnosed focal segmental glomerulosclerosis.</p>
Full article ">Figure 5
<p>Plasma levels of miR-148a-3p in patients with and without diagnosed focal segmental glomerulosclerosis.</p>
Full article ">Figure 6
<p>Plasma levels of miR-425-3p in patients with and without diagnosed focal segmental glomerulosclerosis.</p>
Full article ">Figure 7
<p>Plasma levels of miR-20a-5p in patients with histopathological changes classified as Stage 1 and 2 according to the Haas classification and in patients with Stages 3, 4, and 5, * <span class="html-italic">p</span> = 0.03, Mann–Whitney U test.</p>
Full article ">Figure 8
<p>Plasma levels of miR-148a-3p in patients with histopathological changes classified as Stage 1 and 2 according to the Haas classification and in patients with Stages 3, 4, and 5.</p>
Full article ">Figure 9
<p>Plasma levels of miR-425-3p in patients with histopathological changes classified as Stage 1 and 2 according to the Haas classification and in patients with Stages 3, 4, and 5.</p>
Full article ">
14 pages, 3306 KiB  
Article
MicroRNA-197-3p Transfection: Variations in Cardiomyocyte Gene Expression with Anaesthetics Drugs in a Model of Hypoxia/Reperfusion
by Jose Luis Guerrero-Orriach, Maria Dolores Carmona-Luque, Maria Jose Rodriguez-Capitan and Guillermo Quesada-Muñoz
Pharmaceuticals 2025, 18(2), 146; https://doi.org/10.3390/ph18020146 (registering DOI) - 23 Jan 2025
Abstract
Background: Our research team analyzed the microRNA (miRNA)-197-3p involved in cardioprotection, and we demonstrated that the overexpression of miRNA-197-3p could be linked to a higher risk of cardiac damage. Recent research indicated that miRNA-197-3p inhibits the effector proteins of the anaesthetic preconditioning mechanism [...] Read more.
Background: Our research team analyzed the microRNA (miRNA)-197-3p involved in cardioprotection, and we demonstrated that the overexpression of miRNA-197-3p could be linked to a higher risk of cardiac damage. Recent research indicated that miRNA-197-3p inhibits the effector proteins of the anaesthetic preconditioning mechanism of halogenated drugs. In this scenario, we proposed to determine the role of miRNA-197-3p in cardiac injury and its effects on myocardial conditioning under halogenated exposure. Hypothesis: Patients having myocardial revascularization surgery have increased heart damage due to postoperative miRNA-197-3p upregulation. Methods: Human cardiac myocytes (HCMs) were used in an in vitro hypoxia/reperfusion (H/R) model. The miRNA-197-3p-MIMIC was transfected into the HCMs. Three H/R-induced HCM groups were performed: negative MIMIC-control transfected, MIMIC transfected, and non-transfected. Each H/R cell group was exposed to Propofol (P), Sevoflurane (S), or non-exposed. Healthy cell cultures were the control group. ELISA assays were used to assess the Akt1 and p53 cell secretion capacity, and the Next Generation Sequencing assay was used to measure the differential expression of miRNA targets. Results: The secretion capacity of H/R-induced HCMs transfected with the MIMIC was higher under sevoflurane exposure regarding Akt-1 cytokine (I/R + S: 0.80 ± 0.06 ng/mL; I/R + P: 0.45 ± 0.28 ng/mL; p > 0.05), and lower regarding p53 cytokine (I/R + S: 38.62 ± 6.93 ng/mL; I/R + P: 43.34 ± 15.20 ng/mL; p > 0.05) compared to propofol. In addition, a significant gene overexpression of five miRNAs, in the sevoflurane group, was linked to cardioprotection: miRNA-29-3p, 24-3p, 21-3p, 532, and miRNA-335-5p. Conclusions: miRNA-197-3p inhibits the cardioprotection induced by halogenated exposure and can be considered a biomarker of cardiac damage. Additional research is required to validate our findings in other clinical settings. Full article
(This article belongs to the Special Issue Use of Anesthetic Agents: Management and New Strategy)
Show Figures

Figure 1

Figure 1
<p>Akt-1 and p53 cytokine quantification. (<b>A</b>) Akt-1 supernatant concentration (ng/mL ± Standard Deviation (SD)) in the primary Human Cardiac Myocytes (HCMs) culture. (<b>B</b>) p53 supernatant concentration (ng/mL ± SD) in the HCMs culture. The Hypoxia/Reperfusion procedure was induced in all the HCMs analyzed and were divided into three cell types: HCM non-transfected; HCM transfected with the miRNA-197-3p MIMIC; and HCM transfected with the negative control of the miRNA-197-3pMIMIC. Each HCM type was distributed in three study groups: No drugs, without hypnotic drugs exposure; Propofol, with propofol exposure; and Sevoflurane, with sevoflurane exposure. <span class="html-italic">p</span>-Value non-significant: <span class="html-italic">p</span> &gt; 0.05. (U-Mann Whitney statistical test).</p>
Full article ">Figure 2
<p>Differences between groups and crucial biological processes involved in miRNA modulation in the sevoflurane vs. propofol groups after a hypoxia–reperfusion process induced following miRNA-197-3p MIMIC transfection.</p>
Full article ">Figure 3
<p>Differences between groups and crucial cellular processes involved in miRNA modulation in the sevoflurane group vs. propofol after a hypoxia–reperfusion process induced following miRNA-197-3p MIMIC transfection.</p>
Full article ">Figure 4
<p>Differences between groups and crucial molecular processes involved in miRNA modulation in the sevoflurane vs. propofol groups after a hypoxia–reperfusion process induced following miRNA-197-3p MIMIC transfection.</p>
Full article ">Figure 5
<p>Design of the study groups.</p>
Full article ">Figure 6
<p>Experimental design.</p>
Full article ">
20 pages, 681 KiB  
Review
Promising Biotechnological Applications of the Artificial Derivatives Designed and Constructed from Plant microRNA Genes
by T. N. Erokhina, Ekaterina V. Ryabukhina, Irina S. Lyapina, Dmitry Y. Ryazantsev, Sergey K. Zavriev and Sergey Y. Morozov
Plants 2025, 14(3), 325; https://doi.org/10.3390/plants14030325 - 22 Jan 2025
Abstract
MicroRNAs (miRNAs) are small regulatory RNAs that are expressed in a tissue-specific manner during the development of plants and animals. The genes of miRNAs have been found to produce the following two products: (i) primary transcripts of these genes (pri-miRNA) are processed to [...] Read more.
MicroRNAs (miRNAs) are small regulatory RNAs that are expressed in a tissue-specific manner during the development of plants and animals. The genes of miRNAs have been found to produce the following two products: (i) primary transcripts of these genes (pri-miRNA) are processed to give rise to mature miRNA, and (ii) in some cases, the pri-miRNA molecules can be translated to form small peptides, named as miPEPs. Gene silencing by artificial microRNAs (amiRNAs) is one of the potential crucial methods for the regulation of desired genes to improve horticultural plants. Likewise, external application of chemically synthesized miPEPs may help plants to resist biotic/abiotic stresses and grow faster. These potent and reliable derivatives of miRNA genes can be applied for improving useful traits in crop plants. This review summarizes the progress in research on the artificial gene derivatives involved in regulating plant development, virus and pest diseases, and abiotic stress resistance pathways. We also briefly discuss the molecular mechanisms of relevant target genes for future research on breeding in plants. In general, this review may be useful to researchers who are implementing amiRNA and miPEP for accelerating breeding programs and developmental studies in crop plants. Full article
Show Figures

Figure 1

Figure 1
<p>Schematic representation of the amiRNA pathway in transgenic plants to improve resistance to biotic and abiotic stresses.</p>
Full article ">
12 pages, 521 KiB  
Commentary
Exosomes in Dermatological Research: Unveiling Their Multifaceted Role in Cellular Communication, Healing, and Disease Modulation
by Daniela Pinto, Giammaria Giuliani, Giorgia Mondadori and Fabio Rinaldi
Cosmetics 2025, 12(1), 16; https://doi.org/10.3390/cosmetics12010016 - 22 Jan 2025
Viewed by 133
Abstract
Exosomes, a subtype of extracellular vehicles (EVs), play a pivotal role in cellular communication and have gained considerable attention in dermatological research. Formed through the inward budding of the endosomal membrane, exosomes facilitate the transfer of proteins, lipids, and nucleic acids, including microRNAs [...] Read more.
Exosomes, a subtype of extracellular vehicles (EVs), play a pivotal role in cellular communication and have gained considerable attention in dermatological research. Formed through the inward budding of the endosomal membrane, exosomes facilitate the transfer of proteins, lipids, and nucleic acids, including microRNAs (miRNAs), thereby influencing the behavior and function of recipient cells. These vesicles are secreted by various cell types, including keratinocytes, and are crucial for maintaining skin homeostasis, regulating immune responses, and promoting wound healing. Exosomes have demonstrated therapeutic potential in addressing dermatological conditions such as hair disorders, skin cancers and photoaging through enhanced regeneration and reduced oxidative stress. However, they are also implicated in disease progression, with pathogens utilizing exosome release to evade host immune responses. Recent studies highlight the diverse origins and functions of exosomes, suggesting their promise as innovative therapeutic agents in dermatology. As research continues to elucidate their multifaceted roles, exosomes represent a frontier in understanding intercellular communication and developing novel treatments for skin-related diseases, underscoring their potential impact on both health and clinical applications. This review synthesizes the existing literature on exosome biology and isolation with a focus on their implications in dermatological contexts. Full article
Show Figures

Figure 1

Figure 1
<p>Exosome biogenesis and their potential applications.</p>
Full article ">
23 pages, 903 KiB  
Review
The Therapeutic Potential of MicroRNA-21 in the Treatment of Spinal Cord Injury
by Ahmed Hasan, Alessio Ardizzone, Domenico Giosa, Sarah Adriana Scuderi, Elsa Calcaterra, Emanuela Esposito and Anna Paola Capra
Curr. Issues Mol. Biol. 2025, 47(2), 70; https://doi.org/10.3390/cimb47020070 - 21 Jan 2025
Viewed by 269
Abstract
Spinal cord injury (SCI) involves complex pathological processes that often result in significant and long-term neurological deficits. Increasingly, research has identified microRNA-21 (miR-21) as a pivotal regulator in SCI, with studies focusing on its roles in inflammation, apoptosis, and tissue repair. This review [...] Read more.
Spinal cord injury (SCI) involves complex pathological processes that often result in significant and long-term neurological deficits. Increasingly, research has identified microRNA-21 (miR-21) as a pivotal regulator in SCI, with studies focusing on its roles in inflammation, apoptosis, and tissue repair. This review synthesizes current findings on miR-21’s involvement in post-injury molecular events, emphasizing its interactions with regulatory targets such as Phosphatase and Tensin Homolog (PTEN) and Programmed Cell Death Protein 4 (PDCD4), as well as its broader effects on inflammatory and apoptotic signaling pathways. Evidence from both in vitro and in vivo studies suggests that modulating miR-21 influences lesion size, cellular dynamics, and functional recovery, highlighting its potential as a therapeutic target for SCI. Nonetheless, the clinical translation of miR-21-based therapies poses significant challenges, including the need to optimize dosages, delivery mechanisms, and long-term safety profiles. Further research is crucial to fully delineate miR-21’s therapeutic potential and determine its feasibility for integration into SCI treatment protocols. This review aims to provide a comprehensive overview of miR-21’s roles in SCI pathology, offering insights into the molecular mechanisms underlying recovery and the emerging potential of miR-21 in SCI management to enhance outcomes and quality of life for affected patients. Full article
(This article belongs to the Special Issue Molecular Mechanism and Regulation in Neuroinflammation, 2nd Edition)
Show Figures

Figure 1

Figure 1
<p>Schematic representation of the effects of miR-21 on key signaling pathways involved in SCI, with a focus on axonal regeneration, apoptosis, and inflammation. MiR-21 regulates multiple pathways responding to SCI by targeting multiple components that influence cellular outcomes. The interaction between neurotrophic factors, e.g., BDNF and nerve growth factor (NGF) and their receptors tropomyosin receptor kinase B (TrkB) and P75 activate downstream signaling pathways, such as c-Jun N-terminal Kinase (JNK) and NF-ĸB, contributing to cell survival and regeneration. MiR-21 regulates axonal regeneration by promoting STAT3 phosphorylation and stimulating the expression of regeneration markers: Cyclin D1, Ki67, Glial Fibrillary Acidic Protein (GFAP), and Neuronal Nuclei (NeuN). In parallel, miR-21 decreases apoptosis through the Phosphoinositide 3-Kinase (PI3K)/AKT pathway, which downregulates pro-apoptotic factors, e.g., Casp-3 and Caspase-8 (Casp-8), and by the direct inhibition of PTEN and PDCD4, which provides neuronal protection and enhance survival. Inflammatory responses mediated by IL-1β, IL-6, and TNF-α are attenuated by miR-21 interacting with Transforming Growth Factor-β (TGF-β)/Smad7 signaling and suppressing NF-ĸB, thereby reducing inflammation. In addition, miR-21 modulates the FasL/Fas Receptor (FASR) axis and the Wnt/β-catenin pathway to mitigate cell death further and promote neural repair. Red inhibitory arrows represent the direct inhibition by miR-21, black inhibitory arrows represent the indirect effect of miR-12 on the signaling pathway, and enhancing arrows indicate the regulatory effects of miR-21 on these pathways.</p>
Full article ">
16 pages, 2962 KiB  
Article
Involvement of miR775 in the Post-Transcriptional Regulation of Fructose-1,6-Bisphosphate Aldolase in Maize (Zea mays L.) Leaves Under Hypoxia
by Dmitry N. Fedorin, Anna E. Khomutova, Alexander T. Eprintsev and Abir U. Igamberdiev
Int. J. Mol. Sci. 2025, 26(3), 865; https://doi.org/10.3390/ijms26030865 - 21 Jan 2025
Viewed by 291
Abstract
Different types of microRNA participate in the post-transcriptional regulation of target genes. The content of several hypoxia-dependent miRNAs in plant cells, including miR775, increases in the conditions of oxygen deficiency. Electrophoretic studies of total RNA samples from the leaves of flooded seedlings of [...] Read more.
Different types of microRNA participate in the post-transcriptional regulation of target genes. The content of several hypoxia-dependent miRNAs in plant cells, including miR775, increases in the conditions of oxygen deficiency. Electrophoretic studies of total RNA samples from the leaves of flooded seedlings of maize (Zea mays L.) revealed the presence of two interfering complexes with miR775 at 12 h of hypoxic incubation. A nucleotide sequence analysis of a sample containing the interfering complex of miR775 with mRNA from maize leaves showed a high degree of homology with the ICL/PEPM_KPHMT lyase family domain. It corresponded to a fragment of fructose-1,6-bisphosphate aldolase mRNA. By real-time PCR, we established the dynamics of the content of transcripts of aldolase isoenzyme genes under hypoxia in maize leaves. A decrease in the transcriptional activity of the aldolase 1 gene (Aldo1) correlated with a high content of miR775 in maize leaf cells. The fraction of extracellular vesicles sedimented at 100,000× g, was enriched with miR775. The accumulation of aldolase 2 (Aldo2) mRNA transcripts under hypoxic conditions indicates its participation in maintaining glycolysis when Aldo1 expression is inhibited. We conclude that an increase in the total content of free miR775 and its participation in the suppression of the Aldo1 gene represents an important mechanism in developing the adaptive reaction of cellular metabolism in response to hypoxia. Full article
(This article belongs to the Collection Feature Papers in Molecular Plant Sciences)
Show Figures

Figure 1

Figure 1
<p>Electrophoretic study of the formation of fluorescent mRNA complex from maize leaves with the miR775A-ROX probe at different hours of hypoxic stress.</p>
Full article ">Figure 2
<p>Nucleotide sequences of Sample 1 and Sample 2 (<b>A</b>) and their comparison (<b>B</b>). *—nucleotide match.</p>
Full article ">Figure 3
<p>Determination of the site of attachment of miR775A to the nucleotide sequence of maize aldolase 1 mRNA (LOC100286050).</p>
Full article ">Figure 4
<p>Comparative analysis of amino acid sequences of annotated proteins possessing the ICL/PEPM_KPHMT lyase domain and a fragment of the amino acid sequence based on the sequence of the RNA-interfering complex with maize miR775A. The amino acids (highlighted in gray) that form this domain are indicated on the sequences. #—correspondence of functional amino acids of the lyase domain.</p>
Full article ">Figure 5
<p>Nucleotide sequences of Sample 2 of miR775A and maize glycerol-3-phosphate acyltransferase (GPAT) mRNA with the miR775A attachment site indicated.</p>
Full article ">Figure 6
<p>Relative levels of aldolase isoenzyme genes <span class="html-italic">Aldo1</span> (red squares) and <span class="html-italic">Aldo2</span> (blue circles) transcripts in maize leaves under hypoxia. The expression of the elongation factor ef-1ά reference gene revealed no statistically significant changes during the experiment.</p>
Full article ">Figure 7
<p>Total activity of fructose-1,6-bisphosphate aldolase (red squares) and glucose-6-bisphosphate dehydrogenase (G6PDH) (blue circles) in maize leaves under hypoxia.</p>
Full article ">Figure 8
<p>Photographs of extracellular vesicle fractions P40 and P100 taken using an Olympus CX41 microscope at 1000× magnification. P40 is the vesicle fraction obtained after differential centrifugation at 40,000× <span class="html-italic">g</span> and having a size of &gt;170 nm. P100 is the vesicle fraction isolated after centrifugation at 100,000× <span class="html-italic">g</span> and having a size of up to 147 nm. The bar corresponds to 1000 nm (1 µm).</p>
Full article ">Figure 9
<p>The relative content of miR775A on surface and inside the P100 vesicles in maize leaves under hypoxia.</p>
Full article ">Figure 10
<p>Hypothetical scheme of the participation of miR775A in the stress response of plants under hypoxic conditions. The microRNA is initially transcribed from the precursor gene as a long primary transcript (pri-miR775A), which is processed into the hairpin-shaped precursor (pre-miR775A), and then processed into miR775A. It is transferred from the cell and in association with the AGO1 protein becomes attached to the extracellular vesicle participating in the intercellular communication. It inhibits the expression of the Aldo1 isozyme, which leads to the activation of the expression of the Aldo2 isoenzyme, the rearrangement of glycolysis, and the activation of the oxidative pentose phosphate pathway (OPPP).</p>
Full article ">
21 pages, 2376 KiB  
Article
Anti-HIV-1 Effect of the Fluoroquinolone Enoxacin and Modulation of Pro-Viral hsa-miR-132 Processing in CEM-SS Cells
by Verena Schlösser, Helen Louise Lightfoot, Christine Leemann, Aathma Merin Bejoy, Shashank Tiwari, Jeffrey L. Schloßhauer, Valentina Vongrad, Andreas Brunschweiger, Jonathan Hall, Karin J. Metzner and Jochen Imig
Non-Coding RNA 2025, 11(1), 8; https://doi.org/10.3390/ncrna11010008 - 20 Jan 2025
Viewed by 182
Abstract
Background: Despite tremendous advances in antiretroviral therapy (ART) against HIV-1 infections, no cure or vaccination is available. Therefore, discovering novel therapeutic strategies remains an urgent need. In that sense, miRNAs and miRNA therapeutics have moved intensively into the focus of recent HIV-1-related investigations. [...] Read more.
Background: Despite tremendous advances in antiretroviral therapy (ART) against HIV-1 infections, no cure or vaccination is available. Therefore, discovering novel therapeutic strategies remains an urgent need. In that sense, miRNAs and miRNA therapeutics have moved intensively into the focus of recent HIV-1-related investigations. A strong reciprocal interdependence has been demonstrated between HIV-1 infection and changes of the intrinsic cellular miRNA milieu. This interrelationship may direct potential alterations of the host cells’ environment beneficial for the virus or its suppression of replication. Whether this tightly balanced and controlled battle can be exploited therapeutically remains to be further addressed. In this context, the fluoroquinolone antibiotic Enoxacin has been demonstrated as a potent modulator of miRNA processing. Here, we test the hypothesis that this applies also to selected HIV-1-related miRNAs. Methods: We studied the effect of Enoxacin on HIV-1 replication coupled with miRNA qRT-PCR analysis of HIV-1-related miRNAs in CEM-SS and MT-4 T-cells. The effects of miRNA mimic transfections combined with Enoxacin treatment on HIV-1 replication were assessed. Finally, we employed an in vitro DICER1 cleavage assay to study the effects of Enoxacin on a pro-HIV-1 miRNA hsa-miR-132 processing. Results: We established that Enoxacin, but not the structurally similar compound nalidixic acid, exhibits strong anti-HIV-1 effects in the T-cell line CEM-SS, but not MT-4. We provide experimental data that this effect of Enoxacin is partly attributed to the specific downregulation of mature hsa-miR-132-3p, but not other tested pro- or anti-HIV-1 miRNAs, which is likely due to affecting DICER1 processing. Conclusions: Our findings show an anti-retroviral activity of Enoxacin at least in part by downregulation of hsa-miR-132-3p, which may be relevant for future antiviral therapeutic applications by modulation of the RNA interference pathway. Full article
(This article belongs to the Section Small Non-Coding RNA)
Show Figures

Figure 1

Figure 1
<p>TaqMan qRT-PCR analysis of selected anti- and pro-HIV miRNAs in CEM-SS cells. Cells were treated for 4 and 7 days post-infection with 50 µM final concentration of (<b>a</b>) Enoxacin, (<b>b</b>) nalidixic acid relative to equivalent volume of DMSO control. * <span class="html-italic">p</span> &lt; 0.05 or ** <span class="html-italic">p</span> &lt; 0.01 two-tailed Student’s t-test. Error bars indicate ± 1 s.d.</p>
Full article ">Figure 2
<p>Effect of Enoxacin and nalidixic acid on HIV-1 replication in (<b>a</b>) CEM-SS cells over two to ten days p.i. (red arrows indicate time points of qPCR in (<b>c</b>)) measured by p24-ELISA. (<b>b</b>) Fold inhibition of Enoxacin at 50 µM final concentration on HIV-1 replication compared to controls in CEM-SS and (<b>c</b>) MT-4 cells were spin-infected with HIV-1HXB2 at MOI 0.01 and monitored for p24 expression in cell culture supernatant. Untreated cells infected with HIV-1 served as positive, DMSO treatment as negative and no virus as background controls, respectively. (<span class="html-italic">n</span> = 4, technical duplicates, DMSO control = nominator, fold-inhibition = 1), ** <span class="html-italic">p</span> &lt; 0.01, two-tailed Mann Whitney U test. Error bars indicate ± 1 s.d. (<b>d</b>) Pro-HIV-1 miR-132-3p relative expression mirrors the anti-HIV-1 effect of Enoxacin at days 4 and 7 but not control miR-223 (anti-HIV-1) or miR-23-a (T-cell miRNA) compared to DMSO by qRT-PCR. ** <span class="html-italic">p</span> &lt; 0.01 two-tailed Student’s <span class="html-italic">t</span>-test. Error bars indicate ± 1 s.d., red arrows indicate time points of significance for p24-ELISA and corresponding qPCR.</p>
Full article ">Figure 3
<p>Hsa-miR-132-3p enhances HIV-1 replication in CEM-SS cells. Cells were spin-infected with HIV-1HXB2 at MOI 0.01 and monitored for p24 expression in supernatant at days 0 and 10 post-infection (p.i.) reverse transfected with miR-mimic or scrambled control at 100 nM plus DMSO. DMSO/mock transfection served as negative and cells and virus alone as positive control. Grey arrow indicates time of transfection. <span class="html-italic">n</span> = 2, * <span class="html-italic">p</span> &lt; 0.05 or ** <span class="html-italic">p</span> &lt; 0.01, two-tailed Student’s <span class="html-italic">t</span>-test. Error bars indicate ± 1 s.d.</p>
Full article ">Figure 4
<p>Hsa-miR-132-3p partially rescues Enoxacin-dependent anti-HIV-1 effect in CEM-SS cells. Cells were spin-infected with HIV-1HXB2 at MOI 0.01 and monitored for p24 expression in supernatant over 4 to 10 days post-infection (p.i.) in the presence of 50 µM final concentration of Enoxacin or respective equivalent volume of DMSO control as shown as fold HIV-1 inhibition by p24 ELISA. Untreated cells infected with HIV-1 served as positive control. Cells were reverse transfected in DMSO or Enoxacin treatment with 100 nM concentration of hsa-miR-132-3p mimic or scrambled control. DMSO and Enoxacin treatment with mock transfection served as additional controls. <span class="html-italic">n</span> = 2, two-tailed Mann-Whitney U-test, error bars indicate ± 1 s.d.</p>
Full article ">Figure 5
<p>In vitro DICER1 cleavage assay in CEM-SS lysates (<b>a</b>) or recombinant DICER1 protein alone (<b>b</b>). miR-132 hairpin was 5′- (<b>a</b>) or 3′ (<b>b</b>) γ-phosphate labeled and incubated in 100 µM, 300 µM and 1 mM Enoxacin or DMSO control at 37 °C for between 0 and 60 min and PAGE-gel separated. Pre-miR and miR bands were densitometrically quantified and DICER1 processing effect was plotted as normalized ratio to DMSO (<b>a</b>) or % cleavage (<b>b</b>). Note: See full autoradiograms and other replicates <a href="#app1-ncrna-11-00008" class="html-app">Figure S5</a>. (<b>c</b>) In vitro SHAPE-MaP reactivity scores plotted on RNAstructure prediction of pre-miR-132 in the presence of 150 and 300 µM Enoxacin and negative control (0 µM Enoxacin). Red triangles indicate DICER1 and blue triangles DROSHA cleavage sites. Light red sequences indicate significant structural rearrangements (marked by asterisks) determined by SHAPE scores of Enoxacin treatment vs. control.</p>
Full article ">
20 pages, 3344 KiB  
Article
DNA Damage-Induced Ferroptosis: A Boolean Model Regulating p53 and Non-Coding RNAs in Drug Resistance
by Shantanu Gupta, Daner A. Silveira, José Carlos M. Mombach and Ronaldo F. Hashimoto
Proteomes 2025, 13(1), 6; https://doi.org/10.3390/proteomes13010006 - 20 Jan 2025
Viewed by 308
Abstract
The tumor suppressor p53, in its wild-type form, plays a central role in cellular homeostasis by regulating senescence, apoptosis, and autophagy within the DNA damage response (DDR). Recent findings suggest that wild-type p53 also governs ferroptosis, an iron-dependent cell death process driven by [...] Read more.
The tumor suppressor p53, in its wild-type form, plays a central role in cellular homeostasis by regulating senescence, apoptosis, and autophagy within the DNA damage response (DDR). Recent findings suggest that wild-type p53 also governs ferroptosis, an iron-dependent cell death process driven by lipid peroxidation. Post-translational modifications of p53 generate proteoforms that significantly enhance its functional diversity in regulating these mechanisms. A key target in this process is the cystine/glutamate transporter (xCT), which is essential for redox balance and ferroptosis resistance. Additionally, p53-induced miR-34c-5p suppresses cancer cell proliferation and drug resistance by modulating Myc, an oncogene further influenced by non-coding RNAs like circular RNA NOTCH1 (CricNOTCH1) and long non-coding RNA MALAT1. However, the exact role of these molecules in ferroptosis remains unclear. To address this, we introduce the first dynamic Boolean model that delineates the influence of these ncRNAs and p53 on ferroptosis, apoptosis, and senescence within the DDR context. Validated through gain- and loss-of-function perturbations, our model closely aligns with experimental observations in cancers such as oral squamous cell carcinoma, nasopharyngeal carcinoma, and osteosarcoma. The model identifies crucial positive feedback loops (CricNOTCH1/miR-34c/Myc, MALAT1/miR-34c/Myc, and Myc/xCT) and highlights the therapeutic potential of using p53 proteoforms and ncRNAs to combat drug resistance and induce cancer cell death. Full article
(This article belongs to the Section Multi-Omics Studies that Include Proteomics)
Show Figures

Figure 1

Figure 1
<p>A dynamic Boolean model of ncRNAs and p53 in ferroptosis. Direct black edges ending in arrowheads represent positive regulatory interactions, while those ending in hammerheads indicate negative ones. Dashed black edges ending with hammerheads specify miR-34c targets. Node colors represent function: signaling proteins are white, CricNOTCH1 is an orange rectangle, and lncRNA MALAT1 is a purple rectangle, with miR-34c as a yellow oval. The green rectangle indicates DNA damage. Model outputs are labeled as proliferation, drug resistance, ferroptosis, and apoptosis.</p>
Full article ">Figure 2
<p>The dynamics of the wild-type case network, illustrating five stable states. (<b>A</b>) The leftmost column depicts the DNA damage levels highlighted in the black box, while the rightmost column presents the model outputs—proliferation, drug resistance, ferroptosis, apoptosis, and senescence—in the orange box. Each line represents an endpoint corresponding to the input. Light violet cells denote an inactivation, whereas dark violet cells denote activation. (<b>B</b>,<b>C</b>) Using MaBoSS simulations, we identified steady states under wild-type conditions with and without DNA damage. (<b>B</b>) For this analysis, DDR input was set to 0 (OFF), representing the absence of DNA damage. Under these conditions, the model predicted 100% proliferation and drug resistance, reflecting the baseline state of the system. (<b>C</b>) When DDR input was fully activated (probability = 1), representing maximal DNA damage, the model predicted distinct probabilities for cell fate outcomes: 81% drug resistance, 9% ferroptosis, 4% apoptosis, and 6% senescence. These outcomes sum to 100%, indicating the comprehensive distribution of cellular states in response to DNA damage. Detailed simulation data are available in <a href="#app1-proteomes-13-00006" class="html-app">Data S1</a>.</p>
Full article ">Figure 3
<p>The gain or loss-of-function perturbations of the CricNOTCH1 and lncRNA MALAT1. The stable states identified for distinct scenarios were as follows: CricNOTCH1 E1, lncRNA MALAT1 E1, CricNOTCH1 KO + lncRNA MALAT1 E1, CricNOTCH1 E1 + lncRNA MALAT1 KO, CricNOTCH1 KO + lncRNA MALAT1 KO. E1 represents GoF and KO represents the LoF of the corresponding network element. The leftmost column shows DNA damage levels highlighted in black, and the rightmost column presents the model outputs, which are highlighted in orange: proliferation, drug resistance, ferroptosis, apoptosis, and senescence. Each line represents a single stable state corresponding to the input.</p>
Full article ">Figure 4
<p>Dynamics of p53 and ncRNAs in DDR under the maximized DNA damage input. The DNA damage input (DDR) was initialized with a probability of 1, representing fully active conditions. (<b>A</b>) For the p53_K LoF + miR-34c GoF, we observed 100% senescence. (<b>B</b>) For the p53_A LoF + miR-34c GoF case, we observed 80% ferroptosis and 20% apoptosis. (<b>C</b>) Combined LoF CricNOTCH1 + LoF lncRNA MALAT1 + LoF p53_A led to 65% ferroptosis and 35% apoptosis. (<b>D</b>) Combined LoF CricNOTCH1 + LoF lncRNA MALAT1 + LoF p53_K resulted in 100% senescence, with no ferroptosis or apoptosis observed. (<b>E</b>) A comparison of the LoF CricNOTCH1, LoF lncRNA MALAT1, and LoF p53_A perturbations with in vitro observations. To enhance clarity and precision, fewer than 41 time steps are shown in the panel to highlight the differences among curves. The detailed simulation data can be found in <a href="#app1-proteomes-13-00006" class="html-app">Data S1</a>.</p>
Full article ">Figure 5
<p>The dynamics of p53 and ncRNAs in DDR under maximized DNA damage input. Here, the DNA damage input (DDR) was initialized with a probability of 1, representing fully active conditions. (<b>A</b>) For the p53_K LoF + miR-34c GoF, we observed 100% senescence. (<b>B</b>) For the p53_A LoF + miR-34c GoF case, we observed 80% ferroptosis and 20% apoptosis. (<b>C</b>) The combined LoF CricNOTCH1 + LoF lncRNA MALAT1 + LoF p53_A led to 65% ferroptosis and 35% apoptosis. (<b>D</b>) The combined LoF CricNOTCH1 + LoF lncRNA MALAT1 + LoF p53_K resulted in 100% senescence, with no ferroptosis or apoptosis observed. (<b>E</b>) The combination of GoF Myc and GoF xCT led to 100% drug resistance. (<b>F</b>) The combination of LoF Myc and LoF xCT resulted in 47% ferroptosis, 27% apoptosis, and 26% senescence. To enhance clarity and precision, fewer than 41 time steps are shown in the panel to highlight the differences among curves. Detailed simulation data are available in <a href="#app1-proteomes-13-00006" class="html-app">Data S1</a>.</p>
Full article ">Figure 6
<p>p53 Dynamics in the DDR. Upon DNA damage, p53 is activated and induces Mdm2 expression, which subsequently inhibits p53 activity. Once activated, p53 regulates several critical signaling pathways: it induces p21 to trigger senescence, activates the BIM/BAX axis to initiate apoptosis, and promotes ferroptosis by either directly inhibiting xCT or inducing SAT1 expression. Additionally, p53 activates miR-34c, which suppresses Myc, a potent inducer of CricNOTCH1 and lncRNA MALAT1. By inhibiting Myc, miR-34c reduces the expression of CricNOTCH1 and lncRNA MALAT1. Interestingly, lncRNA MALAT1 directly inhibits p53. Therefore, miR-34c promotes sustained p53 activation by inhibiting Myc, which in turn diminishes MALAT1’s inhibitory effect on p53. In addition, inhibitors (indicated by question mark) of CricNOTCH1 and lncRNA MALAT1 trigger p53-mediated signaling pathways such as ferroptosis, apoptosis and senescence in DDR. Black arrows represent activation, hammerhead arrows represent inhibition, and dotted hammerhead arrows indicate indirect inhibition.</p>
Full article ">
17 pages, 2557 KiB  
Article
Establishment of iPSC-Derived MSCs Expressing hsa-miR-4662a-5p for Enhanced Immune Modulation in Graft-Versus-Host Disease (GVHD)
by Susie Lee, Eung-Won Kim, Hae-Ri Lee, Sun-Ung Lim, Chan Kwon Jung, Young-Ju Kang, Gyung-Ah Jung and Il-Hoan Oh
Int. J. Mol. Sci. 2025, 26(2), 847; https://doi.org/10.3390/ijms26020847 - 20 Jan 2025
Viewed by 235
Abstract
The immune-modulatory effects of mesenchymal stromal cells (MSCs) are widely used to treat inflammatory disorders, with indoleamine 2,4-dioxygenase-1 (IDO-1) playing a pivotal role in suppressing stimulated T-cell proliferation. Taking that three-dimensional (3D) cultures enhance MSCs’ anti-inflammatory properties compared with two-dimensional (2D) cultures, the [...] Read more.
The immune-modulatory effects of mesenchymal stromal cells (MSCs) are widely used to treat inflammatory disorders, with indoleamine 2,4-dioxygenase-1 (IDO-1) playing a pivotal role in suppressing stimulated T-cell proliferation. Taking that three-dimensional (3D) cultures enhance MSCs’ anti-inflammatory properties compared with two-dimensional (2D) cultures, the differentially expressed miRNAs were examined. Thus, we identified hsa-miR-4662a-5p (miR-4662a) as a key inducer of IDO-1 via its suppression of bridging integrator-1 (BIN-1), a negative regulator of the IDO-1 gene. The IDO-1-inducing potential of miR-4662a was conserved across primary MSCs from various donors and sources but exhibited variability. Notably, iPSC-derived MSCs (iMSCs) demonstrated superior IDO-1 induction and immune-modulatory efficacy compared with their donor-matched primary MSCs. Accordingly, iMSCs expressing miR-4662a (4662a/iMSC) exhibited stronger suppressive effects on T-cell proliferation and more potent suppressive effects on graft-versus-host disease (GVHD), improving survival rates and reducing tissue damage in the liver and gut. Our results point to the therapeutic potential of standardized, off-the-shelf 4662a/iMSC as a robust immune-modulating cell therapy for GVHD. Full article
(This article belongs to the Section Molecular Pathology, Diagnostics, and Therapeutics)
Show Figures

Figure 1

Figure 1
<p>Identification of miR-4662a as an immune-modulating factor in MSCs. (<b>A</b>) Schematic diagram of the process for identifying miRNAs differentially expressed in 2D and 3D MSCs. Two independent donor-derived MSCs, #1 and #2, were cultured in either plastic adherent (2D) or spheroid (3D) conditions for 48 h. RNA sequencing was conducted to identify miRNAs with significant differential expressions (|fold change| &gt; 2; <span class="html-italic">p</span> &lt; 0.05). (<b>B</b>) Fold changes in miRNAs differentially expressed between 2D and 3D MSCs from two independent donors are shown (n = 1). (<b>C</b>) Schematic diagram of the process for analyzing the immune-modulating effects of the differentially expressed miRNAs. The MSCs were transfected with agomiR (mimic) for upregulated miRNAs or with antagomiR (inhibitor) for downregulated miRNAs in (<b>B</b>), then analyzed for changes in the expression levels of <span class="html-italic">IDO-1</span> by using RQ-PCR. (<b>D</b>) Changes in the expression levels of <span class="html-italic">IDO-1</span> from 28 candidate mimics/inhibitors in (<b>B</b>) after normalization to <span class="html-italic">HPRT</span>. Shown are the fold changes in expression levels for each mimic/inhibitor compared with the scrambled negative controls.</p>
Full article ">Figure 2
<p>Comparisons of <span class="html-italic">IDO-1</span> induction in various sources of MSCs by miR-4662a. (<b>A</b>) The fold induction of <span class="html-italic">IDO-1</span> expression was compared among the bone marrow or Wharton-jelly-derived MSCs obtained from multiple donors. Fold changes in <span class="html-italic">IDO-1</span> in primary MSCs from each indicated donor were determined using RQ-PCR, normalized to <span class="html-italic">HPRT</span>, and ascertained in comparison to scrambled control (n = 2 for each donor cell). (<b>B</b>) Schematics for the generation of donor-matched iPSC-derived MSCs (iMSC) and studies comparing the primary and donor-matched iMSCs. (<b>C</b>) Comparison of the <span class="html-italic">IDO-1</span>-inducing potential of MSCs from primary BM-MSCs and donor-matched iMSCs. <span class="html-italic">IDO-1</span> expression in primary MSCs or iMSCs after transfection with miR-4662a was assessed using RQ-PCR. Data were normalized to <span class="html-italic">HPRT</span> and are presented as fold changes relative to scrambled miRNA controls (n = 3 for each group; * <span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">Figure 3
<p><span class="html-italic">BIN-1</span> serves as a target of miR-4662a for immunomodulatory effects. (<b>A</b>) Alignment of the miR-4662a sequence with the <span class="html-italic">BIN-1</span> 5′-UTR region. The matching miRNA seed sequence (marked in bold) with the 5′-UTR region of <span class="html-italic">BIN-1</span> is shown. (<b>B</b>–<b>E</b>) Protein levels of BIN-1, IDO-1, and TSG-6 in iMSCs transfected with a scrambled miRNA control (NC/iMSC) or miR-4662a mimic (4662a/iMSC) were analyzed using Western blotting. Shown are the representative plots for the Western blot (<b>B</b>) and their quantification for expression levels normalized to GAPDH, presented as fold changes relative to scrambled miRNA controls (<b>C</b>–<b>E</b>) (n = 3 for each group; * <span class="html-italic">p</span> &lt; 0.05). The samples were derived from the same experiment and the gels/blots were processed in parallel. Full-length images are presented in <a href="#app1-ijms-26-00847" class="html-app">Figure S2</a>. (<b>F</b>) Kynurenine (KYN) concentration in the culture medium of iMSCs transfected with miRNA (NC or miR-4662a). The concentration of KYN, the metabolite of <span class="html-italic">IDO-1</span>, was analyzed using an ELISA (n = 5; ** <span class="html-italic">p</span> &lt; 0.01). (<b>G</b>–<b>I</b>) Quantitative analysis for expression levels of the transcripts for <span class="html-italic">BIN-1</span>, <span class="html-italic">IDO-1</span>, and <span class="html-italic">TSG-6</span> was analyzed using RQ-PCR for NC/iMSC or 4662a/iMSC (n = 3 or 4; * <span class="html-italic">p</span> &lt; 0.05). Data were normalized to <span class="html-italic">HPRT</span> and are shown as fold changes in transcript levels relative to scrambled controls.</p>
Full article ">Figure 4
<p>Gene ontology analysis of miR-4662a for additional immunomodulatory effects. (<b>A</b>) Schematic outline of bioinformatic analysis of immune-modulating effects of miR-4662a. The analysis of gene ontology (GO) and KEGG pathways used miRDB and TargetScan databases, with PantherDB and KEGG Mapper used for pathway visualization. (<b>B</b>) Left: GO analysis for biological process. The top five GO terms with the significance of FDR are shown. The GO (GO:0002440) for factors related to the immune response is highlighted in red. The full GO analysis results are presented in <a href="#app1-ijms-26-00847" class="html-app">Table S3</a> (FC &lt; 0.5 or &gt;1.5; <span class="html-italic">p</span> &lt; 0.05; FDR &lt; 0.05). Right: The genes predicted in GO for immune-modulating effects (GO:0002440) are listed, with experimentally analyzed genes marked in bold. (<b>C</b>) Expression levels of immune-modulating genes (GO:0002440) were analyzed using RQ-PCR in iMSCs transfected with miR-4662a (n = 3 or 4; * <span class="html-italic">p</span> &lt; 0.05). Data were normalized to <span class="html-italic">HPRT</span> and are presented as fold changes relative to scrambled controls.</p>
Full article ">Figure 5
<p>Immune-modulating effects of miR-4662a on T-cells. (<b>A</b>,<b>B</b>) Inhibition of T-cell proliferation by 4662a/iMSC. Peripheral blood mononuclear cells (PBMCs) from normal donors were stained with CFSE and incubated with an absence of iMSCs (PBMC) or co-cultured with NC/iMSC or 4662a/iMSC for 6 days. The decrease in the CFSE intensity by mitotic divisions of T-cells was analyzed using flow cytometry after gating for T-cells (CD3) (CFSE cells; n = 4; *** <span class="html-italic">p</span> &lt; 0.001). (<b>C</b>) <span class="html-italic">IFN-γ</span> expression of T-cells after 6 days of culture was measured using the culture above and RQ-PCR (n = 3; * <span class="html-italic">p</span> &lt; 0.05; *** <span class="html-italic">p</span> &lt; 0.001). Gene expression levels were normalized to HPRT and are presented as fold changes relative to the PBMC group.</p>
Full article ">Figure 6
<p>Suppression of GVHD by 4662a/iMSC in GVHD-model mice. (<b>A</b>) Schematic diagram of the experiment for production of GVHD mouse model analysis of therapeutic effects. Allogenic bone marrow (BM) and splenocytes (SPs) from C57BL/6 mice were transplanted into BALB/c recipients 24 h after irradiation (8.0 Gy IR). Then, 24 h after transplantation, recipient mice were administered iMSCs transfected with a scrambled control or miR-4662a. Daily monitoring was conducted throughout the experiment. (<b>B</b>) Survival rates of the GVHD mice treated with 4662a/iMSC or NC/iMSC (n = 10 for each group). The log-rank <span class="html-italic">p</span>-value of the survival rate is presented on the right side of the graph. The time-dependent number of risks table is shown at the bottom of the survival curve. (<b>C</b>) Histological analysis of intestines in GVHD mice treated with each group of iMSCs. Shown are the hematoxylin and eosin (H&amp;E)-stained intestinal sections of GVHD mice treated with NC/iMSC (upper panels) or 4662a/iMSC (lower panels). The double-headed arrows within the left panels indicate the individual lengths of the villus (Vi) and crypt (Cr). The right panels are 4X magnification images of the boxed inlet region in the left panels. Apoptotic cells and karyorrhectic debris are indicated by yellow arrows (scale bars: left, 200 μm; right, 50 μm). (<b>D</b>) Histology of the liver from H&amp;E staining of GVHD mice. Bile-duct damage and portal inflammation are indicated by yellow arrows (scale bar: 100 μm).</p>
Full article ">Figure 7
<p>Schematic representation of the multiple immune-modulating effects of miR-4662a to suppress GVHD. miR-4662a targets BIN-1, the negative regulator of IDO-1, to cause the inhibition of T-cell proliferation. With the induction of IDO-1, its metabolite kynurenic acid is increased, causing upregulation of TSG-6, thereby inhibiting inflammation by macrophages. Bioinformatic analysis of miR-4662a target gene by GO analysis and KEGG pathway suggested additional immune-modulating effects with decreased expression of the genes for B-cell response (<span class="html-italic">EXOSC6</span>, <span class="html-italic">NFKB1Z</span>, <span class="html-italic">SWAP70</span>, and <span class="html-italic">TRAF3IP2</span>) and antigen presentation (<span class="html-italic">CD28</span>, <span class="html-italic">HLA-A</span>, <span class="html-italic">HLA-E</span>, and <span class="html-italic">IL-6</span>).</p>
Full article ">
15 pages, 8342 KiB  
Article
MicroRNA-129-3p Suppresses Tumor Progression and Chemoradioresistance in Head and Neck Squamous Cell Carcinoma
by Tae Mi Yoon, Sun-Ae Kim, Eun Kyung Jung, Young-Kook Kim, Kyung-Hwa Lee and Sang Chul Lim
Curr. Oncol. 2025, 32(1), 54; https://doi.org/10.3390/curroncol32010054 - 20 Jan 2025
Viewed by 322
Abstract
(1) Background: MicroRNA-129 (miR-129) participates in tumor progression and chemoresistance in various cancer types. In this study, the role of miR-129-3p, the main mature form of miR-129, in tumor progression and chemoradiotherapy resistance in head and neck cancer was evaluated. (2) Methods: RT-PCR, [...] Read more.
(1) Background: MicroRNA-129 (miR-129) participates in tumor progression and chemoresistance in various cancer types. In this study, the role of miR-129-3p, the main mature form of miR-129, in tumor progression and chemoradiotherapy resistance in head and neck cancer was evaluated. (2) Methods: RT-PCR, western blotting, cell proliferation assays, cell apoptosis assays, and cell invasion and migration assays were used. (3) Results: In this study, the miR-129-3p overexpression suppressed the proliferation, invasion, and migration of SNU1041, SCC15, and SCC25 human HNSCC cell lines. Additionally, it induced apoptosis and enhanced radiation-/cisplatin-induced apoptosis of SNU1041, SCC15, and SCC25 cells. Therefore, miR-129-3p could suppress tumor progression and enhance chemoradiosensitivity in human HNSCC. Furthermore, miR-129-3p was downregulated in fresh tumor tissues from patients with HNSCC compared with that in the adjacent normal mucosa. In a nude mouse xenograft model with SNU15 cells, the miR-129-3p overexpression significantly decreased tumor growth, as measured by tumor weight and volume. (4) Conclusions: Our study provides evidence that miR-129-3p suppresses tumor progression and chemoradioresistance in HNSCC. This finding may serve as a basis for developing miR-129-3p-based therapeutic strategies. Full article
(This article belongs to the Section Head and Neck Oncology)
Show Figures

Figure 1

Figure 1
<p>Effect of the miRNA-129-3p overexpression on cell proliferation, invasion, and migration in human HNSCC cells. (<b>A</b>) miR-129-3p mimic-transfected HNSCC cells significantly suppressed the proliferation in the SNU1041, SCC25, and SCC15 cells compared with that in the control cell. (<b>B</b>) Significantly fewer miR-129-3p mimic-transfected SNU1041, SCC25, and SCC15 cells demonstrated the invasion capacity compared with the control cells in a cell invasion assay. Magnification: ×100. The stained invading cells were counted and presented as the mean ± standard error in three independent experiments. (<b>C</b>) The artificial wound gap in the control cells in the cell migration assay became significantly narrower than that in the miR-129-3p mimic-transfected SNU1041, SCC25, and SCC15 cells. Cell migration is displayed as relative healing distances measured in three random sites. Values indicate mean ± SE for three independent experiments. 129-3p mimic, miR-129-3p mimic-transfected cells, * <span class="html-italic">p</span> &lt; 0.05 vs. control.</p>
Full article ">Figure 1 Cont.
<p>Effect of the miRNA-129-3p overexpression on cell proliferation, invasion, and migration in human HNSCC cells. (<b>A</b>) miR-129-3p mimic-transfected HNSCC cells significantly suppressed the proliferation in the SNU1041, SCC25, and SCC15 cells compared with that in the control cell. (<b>B</b>) Significantly fewer miR-129-3p mimic-transfected SNU1041, SCC25, and SCC15 cells demonstrated the invasion capacity compared with the control cells in a cell invasion assay. Magnification: ×100. The stained invading cells were counted and presented as the mean ± standard error in three independent experiments. (<b>C</b>) The artificial wound gap in the control cells in the cell migration assay became significantly narrower than that in the miR-129-3p mimic-transfected SNU1041, SCC25, and SCC15 cells. Cell migration is displayed as relative healing distances measured in three random sites. Values indicate mean ± SE for three independent experiments. 129-3p mimic, miR-129-3p mimic-transfected cells, * <span class="html-italic">p</span> &lt; 0.05 vs. control.</p>
Full article ">Figure 2
<p>Effect of the miRNA-129-3p overexpression on the apoptosis and chemoradioresistance of human HNSCC cells. (<b>A</b>) In a cell apoptosis assay, flow cytometry demonstrated that the apoptosis of miR-129-3p mimic-transfected SNU1041, SCC25, and SCC15 cells was greater than that of the control cells. (<b>B</b>) The combination treatment of miR-129-3p mimic-transfected SNU1041 and SCC25 with 10 or 20 Gy radiation resulted in significantly greater apoptosis than the control treatment (radiation alone). (<b>C</b>) The combination treatment of miR-129-3p mimic-transfected SNU1041 and SCC25 with 10 μg/mL cisplatin resulted in significantly greater apoptosis than the control treatment (cisplatin alone). (<b>D</b>) The levels of cleaved caspase-3, cleaved caspase-7, and cleaved PARP were higher in the miR-129-3p mimic-transfected SNU1041, SCC25, and SCC15 cells than in the control cells. Furthermore, the expression levels of cleaved caspase-3, cleaved caspase-7, and cleaved PARP in the miR-129-3p mimic-transfected cells with the combination treatment (radiation or cisplatin) were greater than those in the control cells with radiation or cisplatin alone. (<b>E</b>) The intensity ratio of each band in the Western blot (<b>D</b>) was presented by densitometry analysis. The uncropped blots are shown in the <a href="#app1-curroncol-32-00054" class="html-app">Supplementary Materials</a>. * <span class="html-italic">p</span> &lt; 0.05 vs. control. 129-3p mimic, miR-129-3p mimic-transfected cells; 7-AAD, 7-amino-actinomycin D; RT, radiation therapy; PARP, poly(ADP-ribose)polymerase; XIAP, X-linked inhibitor of apoptosis protein.</p>
Full article ">Figure 2 Cont.
<p>Effect of the miRNA-129-3p overexpression on the apoptosis and chemoradioresistance of human HNSCC cells. (<b>A</b>) In a cell apoptosis assay, flow cytometry demonstrated that the apoptosis of miR-129-3p mimic-transfected SNU1041, SCC25, and SCC15 cells was greater than that of the control cells. (<b>B</b>) The combination treatment of miR-129-3p mimic-transfected SNU1041 and SCC25 with 10 or 20 Gy radiation resulted in significantly greater apoptosis than the control treatment (radiation alone). (<b>C</b>) The combination treatment of miR-129-3p mimic-transfected SNU1041 and SCC25 with 10 μg/mL cisplatin resulted in significantly greater apoptosis than the control treatment (cisplatin alone). (<b>D</b>) The levels of cleaved caspase-3, cleaved caspase-7, and cleaved PARP were higher in the miR-129-3p mimic-transfected SNU1041, SCC25, and SCC15 cells than in the control cells. Furthermore, the expression levels of cleaved caspase-3, cleaved caspase-7, and cleaved PARP in the miR-129-3p mimic-transfected cells with the combination treatment (radiation or cisplatin) were greater than those in the control cells with radiation or cisplatin alone. (<b>E</b>) The intensity ratio of each band in the Western blot (<b>D</b>) was presented by densitometry analysis. The uncropped blots are shown in the <a href="#app1-curroncol-32-00054" class="html-app">Supplementary Materials</a>. * <span class="html-italic">p</span> &lt; 0.05 vs. control. 129-3p mimic, miR-129-3p mimic-transfected cells; 7-AAD, 7-amino-actinomycin D; RT, radiation therapy; PARP, poly(ADP-ribose)polymerase; XIAP, X-linked inhibitor of apoptosis protein.</p>
Full article ">Figure 2 Cont.
<p>Effect of the miRNA-129-3p overexpression on the apoptosis and chemoradioresistance of human HNSCC cells. (<b>A</b>) In a cell apoptosis assay, flow cytometry demonstrated that the apoptosis of miR-129-3p mimic-transfected SNU1041, SCC25, and SCC15 cells was greater than that of the control cells. (<b>B</b>) The combination treatment of miR-129-3p mimic-transfected SNU1041 and SCC25 with 10 or 20 Gy radiation resulted in significantly greater apoptosis than the control treatment (radiation alone). (<b>C</b>) The combination treatment of miR-129-3p mimic-transfected SNU1041 and SCC25 with 10 μg/mL cisplatin resulted in significantly greater apoptosis than the control treatment (cisplatin alone). (<b>D</b>) The levels of cleaved caspase-3, cleaved caspase-7, and cleaved PARP were higher in the miR-129-3p mimic-transfected SNU1041, SCC25, and SCC15 cells than in the control cells. Furthermore, the expression levels of cleaved caspase-3, cleaved caspase-7, and cleaved PARP in the miR-129-3p mimic-transfected cells with the combination treatment (radiation or cisplatin) were greater than those in the control cells with radiation or cisplatin alone. (<b>E</b>) The intensity ratio of each band in the Western blot (<b>D</b>) was presented by densitometry analysis. The uncropped blots are shown in the <a href="#app1-curroncol-32-00054" class="html-app">Supplementary Materials</a>. * <span class="html-italic">p</span> &lt; 0.05 vs. control. 129-3p mimic, miR-129-3p mimic-transfected cells; 7-AAD, 7-amino-actinomycin D; RT, radiation therapy; PARP, poly(ADP-ribose)polymerase; XIAP, X-linked inhibitor of apoptosis protein.</p>
Full article ">Figure 3
<p>Anti-tumor effect of miRNA-129-3p overexpression on the nude mouse xenograft model. The tumors in the miR-129-3p group showed significantly slower growth in terms of volume and weight. * <span class="html-italic">p</span> &lt; 0.05 vs. control. 129-3p mimic, miR-129-3p mimic-transfected cells implanted group.</p>
Full article ">Figure 4
<p>miR-129-3p expression in the tumor tissues of patients with HNSCC. Of the 16 patients, 12 (75%) showed a lower miR-129-3p expression in the tumor tissues than in the normal mucosa.</p>
Full article ">
16 pages, 1499 KiB  
Article
The Platelet-Specific Gene Signature in the Immunoglobulin G4-Related Disease Transcriptome
by Ali Kemal Oguz, Cagdas Sahap Oygur, Bala Gur Dedeoglu, Irem Dogan Turacli, Sibel Serin Kilicoglu and Ihsan Ergun
Medicina 2025, 61(1), 162; https://doi.org/10.3390/medicina61010162 - 19 Jan 2025
Viewed by 252
Abstract
Background and Objectives: Immunoglobulin G4-related disease (IgG4-RD) is an immune-mediated, fibroinflammatory, multiorgan disease with an obscure pathogenesis. Findings indicating excessive platelet activation have been reported in systemic sclerosis, which is another autoimmune, multisystemic fibrotic disorder. The immune-mediated, inflammatory, and fibrosing intersections of IgG4-RD [...] Read more.
Background and Objectives: Immunoglobulin G4-related disease (IgG4-RD) is an immune-mediated, fibroinflammatory, multiorgan disease with an obscure pathogenesis. Findings indicating excessive platelet activation have been reported in systemic sclerosis, which is another autoimmune, multisystemic fibrotic disorder. The immune-mediated, inflammatory, and fibrosing intersections of IgG4-RD and systemic sclerosis raised a question about platelets’ role in IgG4-RD. Materials and Methods: By borrowing transcriptomic data from Nakajima et al. (GEO repository, GSE66465) we sought a platelet contribution to the pathogenesis of IgG4-RD. GEO2R and BRB-ArrayTools were used for class comparisons, and WebGestalt for functional enrichment analysis. During the selection of differentially expressed genes (DEGs), the translationally active but significantly low amount of platelet mRNA was specifically considered. The platelet-specific gene signature derived was used for cluster analysis of patient and control groups. Results: When IgG4-RD patients were compared with controls, 268 DEGs (204 with increased and 64 with decreased expression) were detected. Among these, a molecular signature of 22 platelet-specific genes harbored genes important for leukocyte–platelet aggregate formation (i.e., CLEC1B, GP1BA, ITGA2B, ITGB3, SELP, and TREML1) and extracellular matrix synthesis (i.e., CLU, PF4, PPBP, SPARC, and THBS1). Functional enrichment analysis documented significantly enriched terms related to platelets, including but not limited to “platelet reactivity”, “platelet degranulation”, “platelet aggregation”, and “platelet activation”. During clustering, the 22 gene signatures successfully discriminated IgG4-RD and the control and the IgG4-RD before and after treatment groups. Conclusions: Patients with IgG4-RD apparently display an activated platelet phenotype with a potential contribution to disease immunopathogenesis. If the platelets’ role is validated through further carefully designed research, the therapeutic potentials of selected conventional and/or novel antiplatelet agents remain to be evaluated in patients with IgG4-RD. Transcriptomics and/or proteomics research with platelets should take into account the relatively low amounts of platelet mRNA, miRNA, and protein. Secondary analysis of omics data sets has great potential to reveal new and valuable information. Full article
(This article belongs to the Section Hematology and Immunology)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Flow diagram of the study. PMID: 25973893 is the article by Nakajima et al. [<a href="#B19-medicina-61-00162" class="html-bibr">19</a>].</p>
Full article ">Figure 2
<p>The graphical representations of the functional enrichment analysis results. While the columns represent the functional databases searched (from left to right, gene ontology, pathway, and disease), the rows represent the DEG sets used (from the top to the bottom, only the DEGs with increased expression levels, only the DEGs with decreased expression levels, and the combined DEG set). * Gene sets regarding platelets, platelet functions, and platelet activation.</p>
Full article ">Figure 3
<p>Graphic representation of the Venn diagram analysis of the platelet-specific gene signature (DEGs PLATELET) and the Reactome database’s “platelet activation, signaling, and aggregation” pathway (REACTOME). REACTOME ∩ DEGs PLATELET includes <span class="html-italic">CLEC1B</span>, <span class="html-italic">CLU</span>, <span class="html-italic">GP1BA</span>, <span class="html-italic">ITGA2B</span>, <span class="html-italic">ITGB3</span>, <span class="html-italic">MMRN1</span>, <span class="html-italic">MPL</span>, <span class="html-italic">P2RY12</span>, <span class="html-italic">PF4</span>, <span class="html-italic">PPBP</span>, <span class="html-italic">PROS1</span>, <span class="html-italic">SELP</span>, <span class="html-italic">SPARC</span>, and <span class="html-italic">THBS1</span>.</p>
Full article ">Figure 4
<p>Dendrogram and heat map representations of the cluster analyses (panels (<b>A</b>,<b>B</b>), where rows represent genes and columns represent samples) and graphical presentations of the relative <span class="html-italic">SELP</span> gene expressions (panels (<b>C</b>,<b>D</b>)). (<b>A</b>) Dendrogram and heat map of the BT and HC clustering; (<b>B</b>) dendrogram and heat map of the BT and AT clustering; (<b>C</b>) relative <span class="html-italic">SELP</span> expression levels during the BT vs. HC class comparison; (<b>D</b>) relative <span class="html-italic">SELP</span> expression levels during the BT vs. AT class comparison.</p>
Full article ">
21 pages, 6149 KiB  
Article
Genome-Wide Characterization of Extrachromosomal Circular DNA in the Midgut of BmCPV-Infected Silkworms and Its Potential Role in Antiviral Responses
by Xinyu Tong, Chao Lei, Yilin Liu, Mei Yin, Huan Peng, Qunnan Qiu, Yongjie Feng, Xiaolong Hu, Chengliang Gong and Min Zhu
Int. J. Mol. Sci. 2025, 26(2), 818; https://doi.org/10.3390/ijms26020818 - 19 Jan 2025
Viewed by 241
Abstract
Extrachromosomal circular DNAs (eccDNAs) has been found to be widespread and functional in various organisms. However, comparative analyses of pre- and post-infection of virus are rarely known. Herein, we investigated the changes in expression patterns of eccDNA following infection with Bombyx mori cytoplasmic [...] Read more.
Extrachromosomal circular DNAs (eccDNAs) has been found to be widespread and functional in various organisms. However, comparative analyses of pre- and post-infection of virus are rarely known. Herein, we investigated the changes in expression patterns of eccDNA following infection with Bombyx mori cytoplasmic polyhedrosis virus (BmCPV) and explore the role of eccDNA in viral infection. Circle-seq was used to analyze eccDNAs in the midgut of BmCPV-infected and BmCPV-uninfected silkworms. A total of 5508 eccDNAs were identified, with sizes varying from 72 bp to 17 kb. Most of eccDNAs are between 100 to 1000 bp in size. EccDNA abundance in BmCPV-infected silkworms was significantly higher than in BmCPV-uninfected silkworms. GO and KEGG analysis of genes carried by eccDNAs reveals that most are involved in microtubule motor activity, phosphatidic acid binding, cAMP signaling pathway, and pancreatic secretion signaling pathways. Several eccDNAs contain sequences of the transcription factor SOX6, sem-2, sp8b, or Foxa2. Association analysis of eccDNA-mRNA/miRNA/circRNA revealed that some highly expressed genes are transcribed from relevant sequences of eccDNA and the transcription of protein coding genes influenced the frequency of eccDNA. BmCPV infection resulted in changes in the expression levels of six miRNAs, but no known miRNAs with altered expression levels due to changes in eccDNA abundance were identified. Moreover, it was found that 1287 and 924 sequences representing back-spliced junctions of circRNAs were shared by the junctions of eccDNAs in the BmCPV-infected and uninfected silkworms, respectively, and some eccDNAs loci were shared by circRNAs on Chromosomes 2, 7, 11, 14, and 24, suggesting some eccDNAs may exert its function by being transcribed into circRNAs. These findings suggest that BmCPV infection alter the expression pattern of eccDNAs, leading to changes in RNA transcription levels, which may play roles in regulating BmCPV replication. In the future, further experiments are needed to verify the association between eccDNA-mRNA/miRNA/circRNA and its function in BmCPV infection. Full article
(This article belongs to the Section Molecular Genetics and Genomics)
Show Figures

Figure 1

Figure 1
<p>Characteristics of eccDNAs in midguts of <span class="html-italic">B. mori</span>. (<b>A</b>) Validation of BmCPV-infected silkworms. (0.0001&lt; *** <span class="html-italic">p</span> &lt; 0.001, n = 3). (<b>B</b>) A schematic overview of the Circle-Seq approach applied for genome-wide profiling of eccDNA from the silkworm midgut. (<b>C</b>) The quantity of eccDNAs across various chromosomes. (<b>D</b>) The number of formed eccDNAs per Mb on each chromosome. (<b>E</b>,<b>F</b>) Heatmap of the distribution of eccDNAs in silkworm midguts on the chromosome in BmCPV-uninfected (<b>E</b>) and BmCPV-infected silkworms (<b>F</b>). (<b>G</b>) The distribution of eccDNA among different genomic elements. (<b>H</b>) Distribution of sizes for eccDNA in BmCPV-infected and uninfected silkworm midguts. (<b>I</b>) Comparison of GC content in the eccDNA locus and its adjacent upstream and downstream regions to the genomic average.</p>
Full article ">Figure 2
<p>Validation of eccDNAs. (<b>A</b>) For each predicted eccDNA, divergent PCR primers were designed to specifically amplify the circular molecules and their junction sites. Five eccDNAs were chosen for additional validation (including Chromosome 1: 9054503–9056429, Chromosome 12: 1637053–1639494, Chromosome 3: 4034829-4036205, Chromosome 10: 1758579–1761576 and Chromosome 1: 4197696–4199055). (<b>B</b>) PCR products validation by Sanger sequencing. Arrow indicated junction site. The red arrow indicates the junction site of eccDNAs.</p>
Full article ">Figure 3
<p>Motif analysis of the sequences flanking the breaking points of eccDNAs. The picture on the left represents the motif of the 10 bp sequences located upstream and downstream of the 5′ breaking points of eccDNA. The picture on the right represents the motif of the 10 bp sequences located upstream and downstream of the 3′ breaking points of eccDNA.</p>
Full article ">Figure 4
<p>Expression patterns of ecccDNA in BmCPV-infected and uninfected midgut and functional annotation of differentially expressed eccDNAs. (<b>A</b>) The quantity of eccDNA co-expressed in BmCPV-infected and uninfected silkworm midguts. CPV-JS represents BmCPV-infected group. Con-JS represents BmCPV-uninfected group. (<b>B</b>) The scatter plot of differentially expressed eccDNAs. (<b>C</b>) The volcano plots of differentially expressed eccDNAs. (<b>D</b>) Heat map and hierarchical clustering of eccDNAs. (<b>E</b>–<b>J</b>) The biological processes, cellular components, and molecular functions are associated with the up-regulated (<b>E</b>–<b>G</b>) and down-regulated (<b>H</b>–<b>J</b>) eccDNAs. (<b>K</b>,<b>L</b>) Analysis of KEGG pathways related to the up-regulated (<b>K</b>) and down-regulated (<b>L</b>) eccDNAs.</p>
Full article ">Figure 5
<p>Association of DEGs with BmCPV infection. (<b>A</b>) The clustering plot of DEGs. (<b>B</b>) The scatter plot of DEGs. (<b>C</b>) The volcano plots of DEGs. (<b>D</b>–<b>I</b>) The biological processes, cellular components, and molecular function related to the up-regulated (<b>D</b>–<b>F</b>) and down-regulated (<b>G</b>–<b>I</b>) genes. (<b>J</b>,<b>K</b>) Analysis of KEGG pathways associated with the up-regulated (<b>J</b>) and down-regulated (<b>K</b>) genes. (<b>L</b>) qPCR validation of RNA-Seq results.</p>
Full article ">Figure 6
<p>DEMs with BmCPV infection. (<b>A</b>) The clustering plot of DEMs. (<b>B</b>) The scatter plot of DEMs. (<b>C</b>) The volcano plots of DEMs. (<b>D</b>–<b>I</b>) The biological processes, cellular components, and molecular function related to the up-regulated (<b>D</b>–<b>F</b>) and down-regulated (<b>G</b>–<b>I</b>) miRNAs. (<b>J</b>,<b>K</b>) Analysis of the KEGG pathways associated with the up-regulated (<b>J</b>) and down-regulated (<b>K</b>) miRNAs. (<b>L</b>) qPCR validation of miRNA-Seq results.</p>
Full article ">Figure 7
<p>Association analysis of eccDNA-mRNA. (<b>A</b>) Association analysis between eccDNA counts in each gene and gene expression profiling. The scatter plot shows the expression levels of individual genes compared to the total expression level of eccDNA linked to each gene. (<b>B</b>) eccDNA abundance and gene density distribution. The scatter plot shows the quantity of genes and eccDNAs per MB of length for each chromosome. (<b>C</b>,<b>D</b>) The sequences representing back-spliced junctions of some circRNAs were shared by junctions of eccDNAs in the BmCPV-infected (<b>C</b>) and -uninfected silkworms (<b>D</b>). (<b>E</b>) Visualization of the genomic locations of eccDNAs and circRNAs loci.</p>
Full article ">
16 pages, 1196 KiB  
Article
miRNAs and Hematological Markers in Non-Alcoholic Fatty Liver Disease—A New Diagnostic Path?
by Agata Michalak, Małgorzata Guz, Joanna Kozicka, Marek Cybulski, Witold Jeleniewicz, Ilona Telejko, Karolina Szczygieł, Ewa Tywanek and Halina Cichoż-Lach
Biomedicines 2025, 13(1), 230; https://doi.org/10.3390/biomedicines13010230 - 18 Jan 2025
Viewed by 615
Abstract
Background: Asymptomatic liver steatosis constitutes an emerging issue worldwide. Therefore, we decided to explore relationships between selected types of microRNAs (miRNAs), serological markers of liver fibrosis and hematological parameters in the course of non-alcoholic fatty liver disease (NAFLD). Methods: Two hundred and seven [...] Read more.
Background: Asymptomatic liver steatosis constitutes an emerging issue worldwide. Therefore, we decided to explore relationships between selected types of microRNAs (miRNAs), serological markers of liver fibrosis and hematological parameters in the course of non-alcoholic fatty liver disease (NAFLD). Methods: Two hundred and seven persons were included in the survey: 97 with NAFLD and 110 healthy controls. Serological concentrations of miR-126-3p, miR-197-3p, and miR-1-3p were measured in all participants. Direct indices of liver fibrosis [procollagen I carboxyterminal propeptide (PICP), procollagen III aminoterminal propeptide (PIIINP), platelet-derived growth factor AB (PDGF-AB), transforming growth factor-α (TGF-α) and laminin] together with indirect markers (AAR, APRI, FIB-4 and GPR) were also evaluated. The assessment of hematological parameters concerned: mean platelet volume (MPV), platelet distribution width (PDW), plateletcrit (PCT), red blood cell distribution width (RDW), MPV to platelet (PLT) ratio (MPR), RDW to PLT ratio (RPR), neutrophil to lymphocyte (LYM) ratio (NLR), PLT to LYM ratio (PLR) and RDW to LYM ratio (RLR). Additionally, the NAFLD fibrosis score and BARD score were applied. Results: The concentration of miR-126-3p and miR-1-3p was higher, and miR-197-3p was lower in the NAFLD group (p < 0.0001). miR-197-3p correlated notably with hematological indices: negatively with PDW (p < 0.05) and positively with PLR (p < 0.05). Conclusions: Significant correlations between miRNA molecules and hematological markers in the course of NAFLD indicate inflammation as a potential background and create new possibilities for a diagnostic approach. Full article
(This article belongs to the Special Issue Fatty Liver Disease: From Mechanisms to Therapeutic Approaches)
Show Figures

Figure 1

Figure 1
<p>ROC curve (blue line) for miR-126-3p in NAFLD group and random classifier (red line). AUC = 0.716, <span class="html-italic">p</span> &lt; 0.0001. A proposed cut-off &gt; 3.95 amol/µL.</p>
Full article ">Figure 2
<p>ROC curve (blue line) for miR-197-3p in NAFLD group and random classifier (red line). AUC = 0.691, <span class="html-italic">p</span> &lt; 0.0001. A proposed cut-off &lt; 0.57 amol/µL.</p>
Full article ">
29 pages, 1508 KiB  
Review
Exosomal Liquid Biopsy in Prostate Cancer: A Systematic Review of Biomarkers for Diagnosis, Prognosis, and Treatment Response
by Yameen Hamid, Rukhshana Dina Rabbani, Rakkan Afsara, Samarea Nowrin, Aruni Ghose, Vasileios Papadopoulos, Konstantinos Sirlantzis, Saak V. Ovsepian and Stergios Boussios
Int. J. Mol. Sci. 2025, 26(2), 802; https://doi.org/10.3390/ijms26020802 - 18 Jan 2025
Viewed by 404
Abstract
Prostate cancer, a leading cause of cancer-related mortality among men, often presents challenges in accurate diagnosis and effective monitoring. This systematic review explores the potential of exosomal biomolecules as noninvasive biomarkers for the diagnosis, prognosis, and treatment response of prostate cancer. A thorough [...] Read more.
Prostate cancer, a leading cause of cancer-related mortality among men, often presents challenges in accurate diagnosis and effective monitoring. This systematic review explores the potential of exosomal biomolecules as noninvasive biomarkers for the diagnosis, prognosis, and treatment response of prostate cancer. A thorough systematic literature search through online public databases (Medline via PubMed, Scopus, and Web of science) using structured search terms and screening using predefined eligibility criteria resulted in 137 studies that we analyzed in this systematic review. We evaluated the findings from these clinical studies, revealing that the load of exosomes in the blood and urine of prostate cancer patients, which includes microRNAs (miRNAs), proteins, and lipids, demonstrates disease-specific changes. It also shows that some exosomal markers can differentiate between malignant and benign hyperplasia of the prostate, predict disease aggressiveness, and monitor treatment efficacy. Notably, miRNA emerged as the most frequently studied biomolecule, demonstrating superior diagnostic potential compared to traditional methods like prostate-specific antigen (PSA) testing. The analysis also highlights the pressing need for a standardised analytic approach through multi-centre studies to validate the full potential of exosomal biomarkers for the diagnosis and monitoring of prostate cancer. Full article
(This article belongs to the Special Issue Exosomes and Non-Coding RNA Research in Health and Disease)
Show Figures

Figure 1

Figure 1
<p>PRISMA flow diagram of the systematic review.</p>
Full article ">Figure 2
<p>Distribution of selected articles based on year of publication.</p>
Full article ">Figure 3
<p>Bar chart of selected article numbers studying different exosomal components as prostate cancer liquid biopsy biomarkers.</p>
Full article ">Figure 4
<p>Bar chart of selected article numbers studying the particular role of exosomal components in prostate cancer.</p>
Full article ">
18 pages, 8509 KiB  
Article
The Potassium Utilization Gene Network in Brassica napus and Functional Validation of BnaZSHAK5.2 Gene in Response to Potassium Deficiency
by Xingzhi Qian, Hanrong Liu, Jie Zhou, Wenyu Zhu, Liping Hu, Xiaoya Yang, Xiwen Yang, Huiyan Zhao, Huafang Wan, Nengwen Yin, Jiana Li, Cunmin Qu and Hai Du
Int. J. Mol. Sci. 2025, 26(2), 794; https://doi.org/10.3390/ijms26020794 - 18 Jan 2025
Viewed by 269
Abstract
Potassium, an essential inorganic cation, is crucial for the growth of oil crops like Brassica napus L. Given the scarcity of potassium in soil, enhancing rapeseed’s potassium utilization efficiency is of significant importance. This study identified 376 potassium utilization genes in the genome [...] Read more.
Potassium, an essential inorganic cation, is crucial for the growth of oil crops like Brassica napus L. Given the scarcity of potassium in soil, enhancing rapeseed’s potassium utilization efficiency is of significant importance. This study identified 376 potassium utilization genes in the genome of B. napus ZS11 through homologous retrieval, encompassing 7 functional and 12 regulatory gene families. These genes are unevenly distributed across 19 chromosomes, and the proteins encoded by these genes are mainly localized in the cell membrane, vacuoles, and nucleus. Microsynteny analysis highlighted the role of small-scale replication events and allopolyploidization in the expansion of potassium utilization genes, identifying 77 distinct types of cis-acting elements within their promoter regions. The regulatory mechanisms of potassium utilization genes were provided by analyses of transcription factors, miRNA, and protein interaction networks. Under low potassium stress, the potassium utilization genes, particularly those belonging to the KUP and CBL families, demonstrate pronounced co-expression. RNA-seq and RT-qPCR analysis identified the BnaZSHAK5.2 gene, which is a high-affinity potassium ion transporter, playing a crucial role in the stress response to potassium deficiency in B. napus, as its expression is strongly induced by low potassium stress. A functional complementation study demonstrates that the BnaZSHAK5.2 gene could rescue the primary root growth of the Athak5 mutant under low potassium conditions, confirming its role in response to low potassium stress by sustaining root development. Full article
(This article belongs to the Special Issue Molecular Genetics and Plant Breeding, 5th Edition)
Show Figures

Figure 1

Figure 1
<p>Subcellular localization of K+ utilization-related proteins in <span class="html-italic">B. napus</span>.</p>
Full article ">Figure 2
<p>Analysis of gene evolution of K+ utilization-related genes in <span class="html-italic">B. napus</span>. (<b>A</b>): Chromosome mapping of K+ utilization genes. (<b>B</b>): Number of K+ utilization genes on each chromosome. (<b>C</b>): Gene duplication event, upper right corner shows duplication events of all K+ utilization genes, and bar chart shows duplication events of functional and regulatory genes of all K+ utilization genes. (<b>D</b>): Linear relationship analysis of <span class="html-italic">B. napus</span> K+ utilization pathway genes and homologous genes in <span class="html-italic">B. rapa</span> and <span class="html-italic">B. oleracea</span> genomes.</p>
Full article ">Figure 3
<p><span class="html-italic">Cis</span>-acting elements of K+ utilization genes in <span class="html-italic">B. napus</span>.</p>
Full article ">Figure 4
<p>K+ deficiency stress expression profile of K+ utilization genes in <span class="html-italic">B. napus</span>. LK: K+ deficiency treatment. “1 d”, “3 d”, “5 d”, “7 d”, and “12 d” represent number of days after K+ deficiency treatment. L: leaf; R: root.</p>
Full article ">Figure 5
<p>Co-expression network of K+ utilization genes in <span class="html-italic">B. napus</span> across different development stages. Orange circles represent transcription factors, and blue “V” shape graphics represent structural genes.</p>
Full article ">Figure 6
<p>Gene expression pattern under potassium deficiency. (<b>A</b>): Differential expression of <span class="html-italic">BnaZSKUPs</span> under K+ deficiency stress. (<b>B</b>): Expression changes of <span class="html-italic">BnaZSHAKs</span> in potassium deficiency. * indicates that the <span class="html-italic">p</span> value is less than 0.5 and ** is less than 0.01.</p>
Full article ">Figure 7
<p>Phenotype analysis of root hair of transgenic <span class="html-italic">Arabidopsis</span>. (<b>A</b>): Phenotype of <span class="html-italic">Arabidopsis</span> root length. (<b>B</b>): Statistics of <span class="html-italic">Arabidopsis</span> root length. a: <span class="html-italic">athak5</span> mutant; b: WT; c: <span class="html-italic">BnaZSHAK5.2p::BnaZSHAK5.2</span>; LK: K+ deficiency; 10 μm and 50 μm represent concentration of K+ in medium; CK: full nutrition. ** indicates that the p value is less than 0.01.</p>
Full article ">
Back to TopTop